424B3: Prospectus
10-Q: Quarterly report
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
EFFECT: Others
424B5: Prospectus
8-K: Current report
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
CERo Therapeutics | DEF 14A: Definitive information statements
CERo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
CERo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
CERo Therapeutics | 8-K/A: Current report (Amendment)
CERo Therapeutics | 10-K: Annual report
CERo Therapeutics | NT 10-K: Others
CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rolfe Lindsey
CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rapaport Robyn
CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN
CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B
CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Corey Daniel
No Data